Literature DB >> 13084843

Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. III. Relationship between inhibitory activity and chemical structure.

I TAMM, K FOLKERS, C H SHUNK, D HEYL, F L HORSFALL.   

Abstract

The degree of inhibition of multiplication of influenza B virus, Lee strain, in membrane cultures in vitro appears to be directly related to the concentration of the inhibitory compounds used in this investigation. With each of the alkyl derivatives of benzimidazole, evidence for such a relationship was obtained in the range between 60 and 90 per cent inhibition of virus multiplication. Alteration of the structure of benzimidazole by substitution of alkyl radicals at various positions in either the benzene or the imidazole ring resulted in diverse differences in the capacity to inhibit influenza virus multiplication in vitro. Minor increases in inhibitory activity resulted when one to three methyl groups were introduced at certain positions in the molecule. Marked increases in inhibitory activity were achieved by more extensive substitution in either the benzene or the imidazole ring. The position and nature of substituent groups appeared to be of decisive importance. Among the more highly active compounds were 2,4,5,6,7-pentamethyl-benzimidazole, 5,6-diethylbenzimidazole, and 2-ethyl-5-methylbenzimidazole. Further extension of the alkyl chain at position 2 caused no significant change in the inhibitory activity of the derivative. The most active compounds studied caused 75 per cent inhibition of Lee virus multiplication in membrane cultures in vitro at concentrations of approximately 0.0002 M. Some of the implications of these findings are discussed.

Entities:  

Keywords:  IMIDAZOLES/effects; INFLUENZA VIRUSES

Mesh:

Substances:

Year:  1953        PMID: 13084843      PMCID: PMC2136243          DOI: 10.1084/jem.98.3.245

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  The influence of chemicals on the propagation of poliomyelitis virus in tissue culture.

Authors:  G C BROWN
Journal:  J Immunol       Date:  1952-10       Impact factor: 5.422

2.  Water-soluble vitamins concerned with one and two-carbon intermediates.

Authors:  A D WELCH; C A NICHOL
Journal:  Annu Rev Biochem       Date:  1952       Impact factor: 23.643

3.  Effects of some metabolic analogs on growth of mumps and influenza viruses in tissue cultures.

Authors:  R T CUSHING; H R MORGAN
Journal:  Proc Soc Exp Biol Med       Date:  1952-03

4.  The effect of 5,6-dimethylbenzimidazole and related compounds on the growth of Lactobacillus lactis Dorner.

Authors:  D HENDLIN; M H SOARS
Journal:  J Bacteriol       Date:  1951-11       Impact factor: 3.490

5.  Further observations of the effect of acridines on the growth of viruses.

Authors:  M D EATON; F S CHEEVER; C G LEVENSON
Journal:  J Immunol       Date:  1951-04       Impact factor: 5.422

6.  The effects of certain amino acids and metabolic antagonists on propagation of Theiler's GD VII virus and P32 uptake by minced one-day-old mouse brain.

Authors:  M E RAFELSON; H E PEARSON; R J WINZLER
Journal:  Arch Biochem       Date:  1950-11

7.  Concerning the relation of the Krebs cycle to virus propagation.

Authors:  W W ACKERMANN; E KLERNSCHMIDT
Journal:  J Biol Chem       Date:  1951-03       Impact factor: 5.157

8.  Studies on the mode of action of aromatic diamidines of influenza and mumps virus in tissue culture.

Authors:  M D EATON; M E PERRY; C G LEVENSON; I M GOCKE
Journal:  J Immunol       Date:  1952-03       Impact factor: 5.422

9.  Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations.

Authors:  I TAMM; K FOLKERS; F L HORSFALL
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

10.  Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. I. Kinetic aspects of inhibition by 2,5-dimethylbenzimidazole as measured by infectivity titrations.

Authors:  I TAMM; K FOLKERS; F L HORSFALL
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

View more
  14 in total

1.  Selective chemical inhibition of influenza B virus multiplication.

Authors:  I TAMM
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

2.  Certain benzimidazoles, benzenes, and ribofuranosylpurines as inhibitors of influenza B virus multiplication.

Authors:  I TAMM; K FOLKERS; C H SHUNK
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

3.  Approaches to the chemotherapy of viral diseases.

Authors:  F L HORSFALL
Journal:  Bull N Y Acad Med       Date:  1955-11

4.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

5.  [Antiviral activity of imidazole derivatives. I. Inhibition of multiplication of mengovirus in FL cells].

Authors:  M Tonew; E M Tonew
Journal:  Arch Gesamte Virusforsch       Date:  1971

6.  Characteristics of the in vitro inhibition of arenavirus synthesis by bis-benzimidazoles.

Authors:  J P Stella; K D Yankaskas; J H Morgan; M P Fox; C J Pfau
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

7.  Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity. Inhibition of poliovirus multiplication and cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole, and its 5-chloroderivative.

Authors:  I TAMM; R BABLANIAN; M M NEMES; C H SHUNK; F M ROBINSON; K FOLKERS
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

8.  The uncoupling of respiratory-chain phosphorylation by 4,5,6,7-tetrachloro-2-trifluoromethylbenzimidazole.

Authors:  R B Beechey
Journal:  Biochem J       Date:  1966-01       Impact factor: 3.857

9.  Antiviral chemotherapy.

Authors:  I TAMM
Journal:  Yale J Biol Med       Date:  1956-09

10.  Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations.

Authors:  I TAMM; K FOLKERS; F L HORSFALL
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.